CS67287A2 - Method of pyrrolo/2,1-a/-isoquinoline-3(2h)-one's new derivatives production - Google Patents

Method of pyrrolo/2,1-a/-isoquinoline-3(2h)-one's new derivatives production

Info

Publication number
CS67287A2
CS67287A2 CS87672A CS67287A CS67287A2 CS 67287 A2 CS67287 A2 CS 67287A2 CS 87672 A CS87672 A CS 87672A CS 67287 A CS67287 A CS 67287A CS 67287 A2 CS67287 A2 CS 67287A2
Authority
CS
Czechoslovakia
Prior art keywords
pyrrolo
isoquinoline
new derivatives
derivatives production
production
Prior art date
Application number
CS87672A
Other languages
Czech (cs)
Inventor
Walter Dr Losel
Otto Dr Roos
Gerd Dr Schnorrenberg
Dietrich Dr Arndts
Franz-Josef Dr Kuhn
Erich Dr Lehr
Richard Dr Reichl
Gunter Dr Schingnitz
Georg Dr Speck
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of CS67287A2 publication Critical patent/CS67287A2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
CS87672A 1986-02-03 1987-02-03 Method of pyrrolo/2,1-a/-isoquinoline-3(2h)-one's new derivatives production CS67287A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863603194 DE3603194A1 (en) 1986-02-03 1986-02-03 NEW 2-AMINO-3-FORMYL-FURANE, METHOD FOR THEIR PRODUCTION AND THE CONTAINING PHARMACEUTICAL COMPOSITIONS

Publications (1)

Publication Number Publication Date
CS67287A2 true CS67287A2 (en) 1990-10-12

Family

ID=6293224

Family Applications (1)

Application Number Title Priority Date Filing Date
CS87672A CS67287A2 (en) 1986-02-03 1987-02-03 Method of pyrrolo/2,1-a/-isoquinoline-3(2h)-one's new derivatives production

Country Status (16)

Country Link
EP (1) EP0234329A1 (en)
JP (1) JPS62185086A (en)
KR (1) KR870007922A (en)
AU (1) AU6823587A (en)
CS (1) CS67287A2 (en)
DD (1) DD260067A5 (en)
DE (1) DE3603194A1 (en)
DK (1) DK52687A (en)
FI (1) FI870435A (en)
HU (1) HU900157D0 (en)
IL (1) IL81447A0 (en)
NO (1) NO870408L (en)
PL (1) PL263934A1 (en)
PT (1) PT84240B (en)
YU (1) YU13787A (en)
ZA (1) ZA87730B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3143876A1 (en) * 1981-11-05 1983-05-11 Boehringer Ingelheim KG, 6507 Ingelheim NEUE1-FURYL-3,4-DIHYDROISOCHINOLINE, MEDICINAL PRODUCTS CONTAINING IT, AND METHOD FOR THE PRODUCTION AND USE THEREOF
DE3401018A1 (en) * 1984-01-13 1985-07-18 Boehringer Ingelheim KG, 6507 Ingelheim METHOD FOR PRODUCING 5,6-DIHYDRO-PYRROLO (2,1-A) ISOCHINOLINES

Also Published As

Publication number Publication date
DK52687A (en) 1987-08-04
PT84240A (en) 1987-03-01
KR870007922A (en) 1987-09-22
PL263934A1 (en) 1988-07-21
NO870408L (en) 1987-08-04
NO870408D0 (en) 1987-02-02
IL81447A0 (en) 1987-09-16
YU13787A (en) 1988-10-31
ZA87730B (en) 1988-10-26
AU6823587A (en) 1987-08-06
DK52687D0 (en) 1987-02-02
DE3603194A1 (en) 1987-08-06
JPS62185086A (en) 1987-08-13
EP0234329A1 (en) 1987-09-02
PT84240B (en) 1991-02-08
FI870435A0 (en) 1987-02-02
FI870435A (en) 1987-08-04
HUT47100A (en) 1989-01-30
DD260067A5 (en) 1988-09-14
HU900157D0 (en) 1990-03-28

Similar Documents

Publication Publication Date Title
CS747588A2 (en) Method of 5-deoxy-5-fluorcytidine's new derivatives production
CS8701093A2 (en) Method of new cycloalkano/1,2-b/-indolesulphoamides production
HU906465D0 (en) Process for producing 3 beta-/4(s)-aryl-oxazolidine-2-one-3-il/-azetidine-2-one derivatives
CS583487A2 (en) Method of new pyrimidine derivatives production
KR950010075B1 (en) Process for the preparation of 1,2,3,6-tetrahydro-5-nitro-pyrimidine derivatives
GR3002288T3 (en) Method for production of stable nicorandil preparation
PL266231A1 (en) The method of manufacture of new derivatives of dilnidropyridine
CS705788A2 (en) Method of purine's new derivatives production
CS554387A2 (en) Method of pyrimidine's new derivatives production
CS392785A2 (en) Method of 1,3-oxazolidine-2-onane's derivatives preparation
CS274677B2 (en) Method of 7-piperazino-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxyl acid's derivatives production
CS523687A2 (en) Method of pyrimidine's new derivatives production
CS872287A2 (en) Method of new triazine's derivatives production
PT83801B (en) Process for preparing 6,7,8,9/tetrahydro-10-methylpyrido]1,2-a"indol-9-amines and derivatives thereof
CS597887A2 (en) Method of new lensofuran-2 ylimidazol derivatives production
CS837885A2 (en) Method of silibinene's new derivatives production
PL279057A1 (en) Method for manufacturing new derivatives of 2-imine-1,3,4-dihydrothiadiazol
PL267418A1 (en) Method of obtaining derivatives of 2,3-dihydrofurene
CS960486A2 (en) Method of pregnale-21-acid's 16,17-acetal-substituted derivatives production
PL270116A1 (en) Method of obtaining novel derivatives of 2,6,7-trioxabicyclo-2,2,2-octane
PL257668A1 (en) Method of obtaining novel derivatives of 4,4-dialkylazethydinone
GB2190081B (en) Method of manufacturing moranoline derivatives
CS311786A2 (en) Method of mitomycin's n7-amidino-substituted derivatives production
CS67287A2 (en) Method of pyrrolo/2,1-a/-isoquinoline-3(2h)-one's new derivatives production
CS910288A2 (en) Method of dioxazocine's derivatives production